{"organizations": [], "uuid": "38f1ecccebc8b9fd9e5d67a28f47bfd0035b9f8d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aratana-therapeutics-confirms-rece/brief-aratana-therapeutics-confirms-receipt-of-board-nominations-idUSFWN1RI0G6", "country": "US", "domain_rank": 408, "title": "BRIEF-Aratana Therapeutics Confirms Receipt Of Board Nominations", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-05T16:42:00.000+03:00", "replies_count": 0, "uuid": "38f1ecccebc8b9fd9e5d67a28f47bfd0035b9f8d"}, "author": "", "url": "https://www.reuters.com/article/brief-aratana-therapeutics-confirms-rece/brief-aratana-therapeutics-confirms-receipt-of-board-nominations-idUSFWN1RI0G6", "ord_in_thread": 0, "title": "BRIEF-Aratana Therapeutics Confirms Receipt Of Board Nominations", "locations": [], "entities": {"persons": [{"name": "board nominati", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "aratana therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 5, 2018 / 1:43 PM / Updated 21 minutes ago BRIEF-Aratana Therapeutics Confirms Receipt Of Board Nominations Reuters Staff \nApril 5 (Reuters) - Aratana Therapeutics Inc: \n* ARATANA THERAPEUTICS CONFIRMS RECEIPT OF BOARD NOMINATIONS \n* INTENDS TO REVIEW QUALIFICATIONS AND EXPERIENCE OF BOARD NOMINEES \n* BOARD AND MANAGEMENT HAVE RECENTLY HELD DISCUSSIONS WITH REPRESENTATIVES OF ENGAGED CAPITAL, DISCUSSIONS ARE ONGOING Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-05T16:42:00.000+03:00", "crawled": "2018-04-05T16:57:34.001+03:00", "highlightTitle": ""}